Temsirolimus in Treating Patients With Locally Advanced or Metastatic Breast Cancer

NCT00376688 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

31

Enrollment

NIH

Sponsor class

Conditions

Recurrent Breast Carcinoma
Stage III Breast Cancer AJCC v7
Stage IIIA Breast Cancer AJCC v7
Stage IIIB Breast Cancer AJCC v7
Stage IIIC Breast Cancer AJCC v7
Stage IV Breast Cancer AJCC v6 and v7

Interventions

OTHER: Laboratory Biomarker Analysis
DRUG: Temsirolimus

Sponsor

National Cancer Institute (NCI)